RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SBRANA A
Collezione ASL Cuneo 2

Items : 3

Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2024 Jul 2;73(9):161. doi: 10.1007/s00262-024-03741-2.

2024
ASL Cuneo 2
AO Ordine Mauriziano

Rescigno P; Fornarini G; Buti S; Rebuzzi SE; Vignani F; Cavo A; Signori A; Banna GL; Tudini M; Malgeri A; Nole F; Prati G; Morelli F; Messina M; Di Napoli M; Atzori F; Prati V; Soraru M; Panni S; Mollica V; Pipitone S; Ricotta R; Fratino L; Catalano F; Milella M; Procopio G; Naglieri E; Masini C; Zucal PA; et alii...

Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study). in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2021 May 18;13:17588359211019642. doi: 10.1177/17588359211019642. eCollection 20

2021
AO Ordine Mauriziano
ASL Cuneo 2

Buti S; Porta C; Perrino M; Brunelli M; Iacovelli R; Paolieri F; Chiellino S; Bersanelli M; Casadei C; Cavo A; Roviello G; Pierantoni F; Prati G; Vignani F; Nolè F; Morelli F; Messina M; Pignata S; Messina C; Stellato M; Atzori F; Soto Parra HJ; Cortellini A; Prati V; Sorarù M; Santoni M; Mollica V; Panni S; Fratino L; et alii...

Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists. in Journal for immunotherapy of cancer / J Immunother Cancer. 2020 Oct;8(2):e001154. doi: 10.1136/jitc-2020-001154.

2020
ASL Cuneo 2

Zivi A; Zampiva I; Zacchi F; von Arx C; Vivaldi C; Ventriglia J; Vitale MG; Vitiello F; Vari S; Trojanello C; Vanella V; Tomei F; Vincenzo T; Trapani D; Taveggia P; Tarantino P; Spada M; Silvestri A; Simeone E; Sbrana A; Santabarbara G; Ascierto PA; Salati M; Rossi A; Russo A; Rosanova M; Riccio V; Piccin L; Pignata S; et alii...